ArticleChinese medicine2025
Exocarpium Citri Grandis ameliorates alcoholic liver disease by modulation of hepatic lipid metabolism and iron homeostasis.
Article in Chinese medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
backgroundAlcoholic liver disease (ALD) is a key cause of chronic liver disease worldwide, which progresses to liver cirrhosis and even hepatocellular carcinoma. After years of application and research, the traditional Chinese medicine (TCM) Exocarpium Citri Grandis (ECG) has shown the significant function of lowering lipid and outering the effect of drinking, but the specific mechanism of its action in ALD is not clear. PURPOSE: The aim of this study is to investigate the anti-alcohol and lipid-lowering effects of ECG and its underlying pharmacological mechanisms in vitro and in vivo.
methodsFirst, this study initiated with a preliminary identification of the active components in the aqueous extract of ECG. Then zebrafish, mice, AML-12 cells and RAW264.7 cells were used as the research object. Serum and hepatic iron concentration were assessed by biochemical assays and iron assay kits. Besides, cells were constructed with the receptor for advanced glycation endproducts (RAGE) overexpression virus for further research.
resultsECG extract was low-toxicity and effectively alleviated alcohol-induced hepatic steatosis in mice and zebrafish. Besides, ECG extract intervention inhibited hepatic iron overload in ALD through mediating the iron-related pathways. Specifically, ECG reversed the down-regulation of ferroportin1 and up-regulation of hepcidin and ferritin in mice liver induced by alcohol, which subsequently suppressed iron dependent-lipid peroxidation and inflammation. In addition, flavonoids were the main components of ECG and could be combined with RAGE. The study indicated that ECG had a superior therapeutic effect against alcohol-induced liver injury in vivo and in vitro.
conclusionsThe protective effect of ECG might be closely related to the modulation of RAGE-mediated lipid accumulation and iron overload. The evidence provides the therapeutic promise of ECG in ALD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.